wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38461521-CAF90F82-AF95-4E9C-9BE0-5F5AA9335907
Q38461521-CAF90F82-AF95-4E9C-9BE0-5F5AA9335907
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38461521-CAF90F82-AF95-4E9C-9BE0-5F5AA9335907
New strategies to develop new medications for lung cancer and metastasis.
P2860
Q38461521-CAF90F82-AF95-4E9C-9BE0-5F5AA9335907
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38461521-CAF90F82-AF95-4E9C-9BE0-5F5AA9335907
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d24aae4bdd402c20a57008396f6f071343e9051
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.